Insiders Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
6.04 ^USD	+5.04%		+13.53%	+116.49%

May. 09	Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M	MT
May. 09	Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lipocine Inc. Announces Senior Leadership Appointments to Advance Its CNS-Focused Pipeline	22-11-03	CI
Lipocine Inc. Announces Board Appointments	22-04-11	CI
Clene Names Morgan Brown as Finance Chief	22-02-01	MT
Lipocine Chief Financial Officer is Retiring	22-01-21	MT
Lipocine Inc. Announces Executive Changes	22-01-21	CI
Lipocine Inc. Announces Resignation of Gregory Bass as Executive Vice President and Chief Commercial Officer, Effective on August 27, 2018	18-08-17	CI
Lipocine Inc. Terminates the Employment of Jyrki Mattila as Executive Vice President and Chief Business Officer	17-07-07	CI
Lipocine Inc. Announces the Promotion of Gregory Bass to Executive Vice President and Chief Commercial Officer	17-02-15	CI
Lipocine Appoints Jyrki Mattila as Executive Vice President and Chief Business Officer	15-05-19	CI
Lipocine Inc. Announces Board Resignations	14-11-14	CI
Lipocine Inc. Announces Changes to the Board of Directors	14-01-07	CI
Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer	13-09-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW